Borderline product

A product whose regulatory status is unclear — whether it is a device, a medicinal product, a cosmetic, a biocide or something else. Member States may ask the Commission to determine the status of a specific product or group of products by implementing act, after consulting the MDCG.

Reference: MDR Article 4; IVDR Article 3

Previous
Previous

Benefit-risk determination

Next
Next

BtX — Breakthrough device